[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69430975D1 - Verfahren zur Herstellung von Proteinen - Google Patents

Verfahren zur Herstellung von Proteinen

Info

Publication number
DE69430975D1
DE69430975D1 DE69430975T DE69430975T DE69430975D1 DE 69430975 D1 DE69430975 D1 DE 69430975D1 DE 69430975 T DE69430975 T DE 69430975T DE 69430975 T DE69430975 T DE 69430975T DE 69430975 D1 DE69430975 D1 DE 69430975D1
Authority
DE
Germany
Prior art keywords
production
desired protein
proteins
recovering
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69430975T
Other languages
English (en)
Other versions
DE69430975T2 (de
Inventor
Kazuaki Furukawa
Keijiro Sugimura
Kazuhiro Ohsuye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daichi Suntory Pharma Co Ltd Tokio/tokyo Jp
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of DE69430975D1 publication Critical patent/DE69430975D1/de
Application granted granted Critical
Publication of DE69430975T2 publication Critical patent/DE69430975T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69430975T 1993-09-08 1994-09-07 Verfahren zur Herstellung von Proteinen Expired - Fee Related DE69430975T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5257881A JPH0775593A (ja) 1993-09-08 1993-09-08 蛋白質の製造方法

Publications (2)

Publication Number Publication Date
DE69430975D1 true DE69430975D1 (de) 2002-08-22
DE69430975T2 DE69430975T2 (de) 2003-01-23

Family

ID=17312486

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69430975T Expired - Fee Related DE69430975T2 (de) 1993-09-08 1994-09-07 Verfahren zur Herstellung von Proteinen

Country Status (7)

Country Link
US (1) US5834249A (de)
EP (1) EP0649900B1 (de)
JP (1) JPH0775593A (de)
AT (1) ATE220714T1 (de)
CA (1) CA2131659A1 (de)
DE (1) DE69430975T2 (de)
ES (1) ES2176224T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001017514A1 (en) * 1999-09-03 2001-03-15 The Salk Institute For Biological Studies Modulation of gene expression by modulating histone acetylation
US6544957B2 (en) 2000-01-04 2003-04-08 The Johns Hopkins University Methods and reagents for facilitating transcription
DE60138658D1 (de) * 2000-09-29 2009-06-18 Topotarget Uk Ltd Carbaminsäurederivate enthaltend eine Amidgruppe zur Behandlung von Malaria
WO2002030879A2 (en) * 2000-09-29 2002-04-18 Prolifix Limited Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors
GB0023983D0 (en) * 2000-09-29 2000-11-15 Prolifix Ltd Therapeutic compounds
WO2003033678A2 (en) * 2001-10-18 2003-04-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
MXPA04009490A (es) * 2002-04-03 2005-06-08 Topo Target Uk Ltd Compuesto de acido carbamico que comprenden un enlace de piperazina como inhibidores de histona desacetilasa.
CA2513246A1 (en) 2003-01-17 2004-08-05 Topotarget Uk Limited Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors
AU2004215624B2 (en) * 2003-02-25 2011-06-02 Topotarget Uk Limited Hydroxamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
US20070026012A1 (en) 2005-08-01 2007-02-01 Cornell Research Foundation, Inc. Compositions and methods for monitoring and altering protein folding and solubility
WO2007024877A2 (en) 2005-08-22 2007-03-01 Cornell Research Foundation, Inc. Compositions and methods for analyzing protein interactions
US20130045871A1 (en) 2010-03-18 2013-02-21 Cornell University Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
US9051901B2 (en) 2011-06-07 2015-06-09 Ford Global Technologies, Llc Exhaust gas recirculation (EGR) system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS215108B2 (en) * 1977-07-15 1982-07-30 Wellcome Found Method of making the interferrone
US4218478A (en) * 1979-01-05 1980-08-19 Ruiko Oiwa Trichostatin as an antiprotozoal agent
JPS5917960B2 (ja) * 1979-09-25 1984-04-24 住友ゴム工業株式会社 刻印用電気ごて
JPS5774093A (en) * 1980-10-27 1982-05-10 Ajinomoto Co Inc Method of increasing interferon production
JPS6018398B2 (ja) * 1982-10-29 1985-05-10 工業技術院長 インタ−フエロンの効率的生産法
JPS6018398A (ja) * 1984-06-12 1985-01-30 松下電器産業株式会社 電気鉛筆削り機
JPS61176523A (ja) * 1985-01-30 1986-08-08 Teruhiko Beppu 制癌剤
US5324640A (en) * 1986-09-20 1994-06-28 Suntory Limited Human B-cell differentiation factor and process of producing said factor
JPH01257492A (ja) * 1987-03-05 1989-10-13 Green Cross Corp:The 異種蛋白質の生産増強方法
JP2598050B2 (ja) * 1987-07-17 1997-04-09 サントリー株式会社 C−末端α−アミド化酵素
JPH01224381A (ja) * 1988-03-04 1989-09-07 Japan Tobacco Inc トリコスタチン酸、トリコスタチンaの新規な合成中間体、及びトリコスタチン酸、トリコスタチンaの製造方法。
JP2535398B2 (ja) * 1989-01-17 1996-09-18 サントリー株式会社 アミド化ペプチドの製造方法
JPH047648A (ja) * 1990-04-24 1992-01-13 Mitsubishi Electric Corp マイクロコンピュータ
JPH0532031A (ja) * 1991-05-23 1993-02-09 Tokyo Electric Co Ltd インクリボンカートリツジ
AU4190893A (en) * 1992-07-17 1994-01-20 Suntory Limited Megakaryocyte differentiation factor

Also Published As

Publication number Publication date
US5834249A (en) 1998-11-10
ES2176224T3 (es) 2002-12-01
EP0649900A2 (de) 1995-04-26
ATE220714T1 (de) 2002-08-15
CA2131659A1 (en) 1995-03-09
EP0649900A3 (de) 1996-07-03
EP0649900B1 (de) 2002-07-17
JPH0775593A (ja) 1995-03-20
DE69430975T2 (de) 2003-01-23

Similar Documents

Publication Publication Date Title
ATE406435T1 (de) Methoden zur züchtung von tierzellen
ES2142363T3 (es) Materiales y metodos para la hipersecrecion de aminoacidos.
DE59610898D1 (de) Verfahren zur herstellung von erythropoietin frei von tierischen proteinen
DE69530242D1 (de) Verfahren zur Herstellung von Glutaminsäure durch Fermentation
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
ATE124725T1 (de) Verbessertes verfahren zur herstellung von faktor viii:c-typ-proteinen.
DE68925138D1 (de) Verfahren zur Herstellung von Proteinen durch Verwendung von CKS-Fusionsproteinen
ATE361360T1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
ATE44047T1 (de) Verfahren zur herstellung von interferonen.
DE69126646D1 (de) Biologisches Verfahren zur Herstellung von optisch-aktiver Milchsäure
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
DE3485336D1 (de) Verfahren zur expression von alpha-1-antitrypsin in bakterien und dessen verwendung in therapeutischen zusammensetzungen sowie vektoren und bakterien fuer ein solches verfahren und deren herstellung.
DE3862306D1 (de) Verfahren zur elektrochemischen herstellung von carbonsaeuren.
ATE154393T1 (de) Verfahren zur herstellung von trans-l-hydroxy- prolin
DE59606567D1 (de) Neuer Mikroorganismus, dessen Verwendung und Verfahren zur Herstellung von L-Alpha-Aminosäuren
DE59108128D1 (de) Verfahren zur Herstellung von Fremdproteinen in Streptomyceten
DE3888386D1 (de) Verfahren zur Herstellung von Proteinen.
DE3575743D1 (de) Verfahren zur gewinnung von phenylalanin-dehydrogenase enthaltenden mikroorganismen und deren verwendung zur herstellung von l-alpha-aminosaeuren.
ATE180837T1 (de) Verfahren zur herstellung von häm-proteinen
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
DE3882413D1 (de) L-valin produzierender mikroorganismus und ein verfahren zur herstellung von l-valin durch gaerung.
DE3685337D1 (de) Verfahren zur herstellung von amiden unter verwendung von mikroorganismen.
DE3677421D1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee